Structure-antitumor activity relationship of hybrid acetogenins focusing on connecting groups between heterocycles and the linker moiety.

Ohta, Kaito; Fushimi, Tetsuya; Okamura, Mutsumi; Akatsuka, Akinobu; Dan, Shingo; Iwasaki, Hiroki; Yamashita, Masayuki; Kojima, Naoto

Ohta, Kaito; Fushimi, Tetsuya; Okamura, Mutsumi; Akatsuka, Akinobu; Dan, Shingo; Iwasaki, Hiroki; Yamashita, Masayuki; Kojima, Naoto.

Affiliation

Ohta K; Kyoto Pharmaceutical University 1 Misasagi-Shichono-cho, Yamashina-ku Kyoto 607-8412 Japan kojima@mb.kyoto-phu.ac.jp.
Fushimi T; Graduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan.
Okamura M; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research 3-8-1 Ariake-ku Tokyo 135-8550 Japan.
Akatsuka A; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research 3-8-1 Ariake-ku Tokyo 135-8550 Japan.
Dan S; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research 3-8-1 Ariake-ku Tokyo 135-8550 Japan.
Iwasaki H; Kyoto Pharmaceutical University 1 Misasagi-Shichono-cho, Yamashina-ku Kyoto 607-8412 Japan kojima@mb.kyoto-phu.ac.jp.
Yamashita M; Kyoto Pharmaceutical University 1 Misasagi-Shichono-cho, Yamashina-ku Kyoto 607-8412 Japan kojima@mb.kyoto-phu.ac.jp.
Kojima N; Kyoto Pharmaceutical University 1 Misasagi-Shichono-cho, Yamashina-ku Kyoto 607-8412 Japan kojima@mb.kyoto-phu.ac.jp.

RSC Adv ; 12(25): 15728-15739, 2022 May 23.

Article de En | MEDLINE | ID: mdl-35685710

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: RSC Adv Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google